Craig Fraser joined Windtree in February of 2016 as President and Chief Executive Officer. He was also appointed to serve as a member of the Board of Directors in February 2016.
Craig brings over 28 years of experience as a leader in both product development and commercial operations and in building biopharmaceutical and device businesses for both startups and larger companies. Prior to joining the company, page he held executive positions at several biopharmaceutical companies, including as Chief Operating Officer at Aegerion Pharmaceuticals, Vice President of Global Disease Areas at Pfizer, Vice President and Global Business Manager at Wyeth, and Vice President of Sales & Marketing and Commercial Operations at Johnson & Johnson / Centocor. Mr. Fraser is a veteran of both the U.S. Marine Corps and the U.S. Army.
Craig received his B.S. degree from Slippery Rock University of Pennsylvania.
Steve Simonson joined Windtree in May of 2014 as Vice President, Clinical Development and was appointed Senior Vice President and Chief Development Officer in October 2014.
Steve has a significant background in pulmonary critical care, bringing over 25 years of medical practice and pharmaceutical industry clinical trial expertise including all phases of drug development. Prior to joining the company, he held executive positions with several companies including Executive Director in the Molecular Development Group at Covance, Vice President of Clinical Development at Agennix, Inc., and various positions at AstraZeneca, where he spent 15 years in medical and clinical leadership.
Steve received his medical degree from the Medical College of Wisconsin, his Masters of Health Sciences degree in Biometry from Duke University School of Medicine and completed his training in internal medicine followed by a fellowship in pulmonary and critical care medicine at Duke University Medical Center.
John Tattory joined Windtree in January of 2008 as Vice President, Finance and was appointed Senior Vice President and Chief Financial Officer in March 2014.
John has more than 25 years of financial management and leadership experience including directing U.S. and international financial operations, strategic transactions, licensing and collaboration arrangements, and equity and debt financings. Prior to joining the company, Mr. Tattory served as a Finance Director, Financial Planning & Analysis at Tyco International Ltd., Finance Director, U.S Primary Care at Bristol-Myers Squibb, and Audit Manager at Ernst & Young.
John received a B.S. degree in Accounting from Rider University and is a certified public accountant.
Mary Templeton joined Windtree in March of 2006 as Senior Vice President and Deputy General Counsel, and was appointed Senior Vice President, General Counsel, and Corporate Secretary in September 2011.
Mary has more than 35 years of senior-level legal executive management experience. Prior to joining the company, Ms. Templeton served as Senior Vice President, General Counsel and Corporate Secretary of the Charles Schwab Corporation (San Francisco), Senior Vice President, General Counsel and Corporate Secretary of The Sequor Group Inc. (New York), and Director of Investment Company Products at Charles Schwab & Co., Inc., and spent several years in private practice in Philadelphia and New York.
Mary received a B.A. degree (Philosophy) from Chatham University, where she serves as a member of the Board of Trustees, and a J.D. degree with High Honors from Rutgers University Law School, where she served as Editor-in-Chief of the Law Journal. She is a member of the New York and Pennsylvania Bar Associations.
Kathy Cole joined Windtree in January 2006 as Senior Vice President, Human Resources.
Kathy has more than 20 years of extensive HR experience, mostly in the life science industry, managing change while closely aligning HR strategy with business objectives to ensure a focused, results driven organization. Prior to joining the company, Ms. Cole served as Vice President, Human Resources for Savient Pharmaceuticals, Inc., in addition to other human resource management positions of increasing responsibility for Cytogen Corporation, EpiGenesis Pharmaceuticals, LLC, and the Prudential Insurance Company of Amercia.
Kathy received her undergraduate degree in Communications from Douglass College and her Master of Science degree in Industrial Relations and Human Resources from the Rutgers University School of Management and Labor Relations.
Larry Weinstein joined Windtree in May of 2014 as Vice President, Medical Device Development.
Larry has over 30 years of respiratory medical device experience including direct experience with capillary-based technology, new product development, successful launch of several respiratory products, as well as operational excellence and quality assurance. Prior to joining the company, he served as President and Chief Operating Officer for ALR Technologies, Vice President of Product Technology at PARI, President of Hydrate, Inc., Senior Vice President of Operations for PRE Holding, Director of Technology for DHD Healthcare as well as several roles of increasing responsibility with Cordis Corporation. Mr. Weinstein is a named inventor on over 20 U.S. patents. He is the author or co-author of over 20 published articles, abstracts and posters in aerosol drug delivery and respiratory humidification.
Larry received his M.B.A. and a M.S. degree in Industrial Engineering from the University of Miami.